Wise Management of Ovarian Cancer: On the Cutting Edge
Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality among women. Two-thirds of patients present at advanced stage at diagnosis, and the estimated 5 year survival rate is 20–40%. This heterogeneous group of malignancies has distinguishable etiology and molecular biology. In...
Main Authors: | Stergios Boussios, Christos Mikropoulos, Eleftherios Samartzis, Peeter Karihtala, Michele Moschetta, Matin Sheriff, Afroditi Karathanasi, Agne Sadauskaite, Elie Rassy, Nicholas Pavlidis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/10/2/41 |
Similar Items
-
BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside
by: Stergios Boussios, et al.
Published: (2022-08-01) -
Tumors defective in homologous recombination rely on oxidative metabolism: relevance to treatments with PARP inhibitors
by: Álvaro Lahiguera, et al.
Published: (2020-06-01) -
PARP Inhibitor Resistance Mechanisms and Implications for Post-Progression Combination Therapies
by: Elizabeth K. Lee, et al.
Published: (2020-07-01) -
STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition
by: Jie Zhou, et al.
Published: (2023-12-01) -
Inhibition of ATM with KU-55933 Sensitizes Endometrial Cancer Cell Lines to Olaparib
by: Zhang A, et al.
Published: (2023-12-01)